We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
-0.36%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$5.84B
AUM Growth
-$10.1M
Cap. Flow
+$52.5M
Cap. Flow %
0.9%
Top 10 Hldgs %
63.1%
Holding
963
New
117
Increased
503
Reduced
219
Closed
73

Sector Composition

Rank Sector Weight
1 Technology 6.62%
2 Financials 3.18%
3 Healthcare 2.12%
4 Communication Services 2.02%
5 Consumer Discretionary 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SXC icon
776
SunCoke Energy
SXC
$815M
$204K ﹤0.01%
19,041
+3,102
+19% +$33.2K
IWO icon
777
iShares Russell 2000 Growth ETF
IWO
$14.8B
$203K ﹤0.01%
707
TITN icon
778
Titan Machinery
TITN
$448M
$203K ﹤0.01%
14,355
-3,120
-18% -$45.2K
LW icon
779
Lamb Weston
LW
$7.16B
$203K ﹤0.01%
+3,032
New +$226K
SOFI icon
780
SoFi Technologies
SOFI
$23.4B
$203K ﹤0.01%
13,151
-31
-0.2% -$403
TXNM
781
TXNM Energy Inc
TXNM
$5.92B
$202K ﹤0.01%
+4,117
New +$190K
TYL icon
782
Tyler Technologies
TYL
$12.5B
$202K ﹤0.01%
350
+1
+0.3% +$604
NUE icon
783
Nucor
NUE
$61.9B
$202K ﹤0.01%
1,729
-213
-11% -$30.6K
JKHY icon
784
Jack Henry & Associates
JKHY
$11.2B
$201K ﹤0.01%
+1,149
New +$205K
NCLH icon
785
Norwegian Cruise Line
NCLH
$8.89B
$200K ﹤0.01%
+7,786
New +$197K
MMSI icon
786
Merit Medical Systems
MMSI
$5.24B
$200K ﹤0.01%
+2,071
New +$206K
CORT icon
787
Corcept Therapeutics
CORT
$11.7B
$200K ﹤0.01%
+3,974
New +$208K
RPRX icon
788
Royalty Pharma
RPRX
$25.4B
$200K ﹤0.01%
+7,846
New +$208K
UAL icon
789
United Airlines
UAL
$41.9B
$200K ﹤0.01%
+2,061
New +$174K
BSAC icon
790
Banco Santander Chile
BSAC
$16.8B
$199K ﹤0.01%
10,564
-260
-2% -$5.08K
FPF
791
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.07B
$199K ﹤0.01%
+11,041
New +$207K
FPE icon
792
First Trust Preferred Securities and Income ETF
FPE
$6.34B
$196K ﹤0.01%
+11,080
New +$199K
CX icon
793
Cemex
CX
$16.3B
$193K ﹤0.01%
34,210
+4,474
+15% +$25.4K
ASPN icon
794
Aspen Aerogels
ASPN
$571M
$189K ﹤0.01%
15,914
+2,565
+19% +$43.7K
PGNY icon
795
Progyny
PGNY
$2.37B
$187K ﹤0.01%
+10,829
New +$168K
AAL icon
796
American Airlines Group
AAL
$10.6B
$186K ﹤0.01%
+10,679
New +$154K
TMCI icon
797
Treace Medical Concepts
TMCI
$284M
$186K ﹤0.01%
25,009
+2,314
+10% +$15.5K
CMRE icon
798
Costamare
CMRE
$1.8B
$176K ﹤0.01%
13,723
-539
-4% -$7.42K
PGRE
799
DELISTED
Paramount Group
PGRE
$176K ﹤0.01%
35,696
-2,242
-6% -$11.1K
CLB icon
800
Core Laboratories
CLB
$513M
$174K ﹤0.01%
10,062
-39
-0.4% -$753

Similar funds

Ballentine Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Ballentine Partners held 963 positions worth $5.84B, down 0.17% from $5.85B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Ballentine Partners's Q4 2024 filing shows 117 new, 503 increased, 219 reduced and 73 closed positions. Its largest new stake was iShares Core S&P US Value ETF: 20,365 shares worth $1.89M. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $8.25M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

  • Ballentine Partners's largest Q4 2024 buy was iShares Core S&P US Value ETF: 20,365 shares worth $1.89M.
  • Ballentine Partners added most to iShares Core S&P Mid-Cap ETF in Q4 2024, an estimated $5.07M increase.
  • Ballentine Partners's biggest Q4 2024 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $8.25M.
  • Ballentine Partners fully exited Huntington Ingalls Industries in Q4 2024, selling an estimated $752K.
  • Ballentine Partners's ten largest holdings make up 63% of its $5.84B portfolio in Q4 2024.
  • Ballentine Partners opened 117 new positions and closed 73 in Q4 2024.
  • Ballentine Partners's portfolio value fell 0.17% quarter-over-quarter to $5.84B.

Based on Ballentine Partners's 13F filing for Q4 2024, filed 16 Jan 2025.